Selective gene silencing in activated leukocytes by targeting siRNAs to the integrin lymphocyte function-associated antigen-1.
about
T cell-specific siRNA delivery suppresses HIV-1 infection in humanized miceTargeting Th17 Cells with Small Molecules and Small Interference RNATargeted Delivery of Small Interfering RNA to Human Dendritic Cells To Suppress Dengue Virus Infection and Associated Proinflammatory Cytokine ProductionNanomedicines based on recombinant fusion proteins for targeting therapeutic siRNA oligonucleotides.Knocking down disease: a progress report on siRNA therapeuticsSystemic leukocyte-directed siRNA delivery revealing cyclin D1 as an anti-inflammatory targetA combinatorial library of lipid-like materials for delivery of RNAi therapeutics.Combinatorial libraries against libraries for selecting neoepitope activation-specific antibodies.Advances in Systemic siRNA DeliveryA Nonpolycationic Fully Proteinaceous Multiagent System for Potent Targeted Delivery of siRNA.Aptamer-targeted cell-specific RNA interferenceRNAi-mediated CCR5 silencing by LFA-1-targeted nanoparticles prevents HIV infection in BLT miceProduction and characterization of a recombinant single-chain antibody against Hantaan virus envelop glycoprotein.How stem cells speak with host immune cells in inflammatory brain diseasesA status report on RNAi therapeutics.Oncomodulin/truncated protamine-mediated Nogo-66 receptor small interference RNA delivery promotes axon regeneration in retinal ganglion cellsImage-guided breast tumor therapy using a small interfering RNA nanodrugRNAi-based therapeutics-current status, challenges and prospectsInhibition of HIV transmission in human cervicovaginal explants and humanized mice using CD4 aptamer-siRNA chimeras.Humanized mice for studying human leukocyte integrins in vivoDesign and characterization of novel recombinant listeriolysin O-protamine fusion proteins for enhanced gene delivery.Anti-CD22 antibody targeting of pH-responsive micelles enhances small interfering RNA delivery and gene silencing in lymphoma cellsIL12B expression is sustained by a heterogenous population of myeloid lineages during tuberculosis.Harnessing RNAi nanomedicine for precision therapyOptimizing siRNA delivery to the genital mucosaThe targeted delivery of multicomponent cargos to cancer cells by nanoporous particle-supported lipid bilayers.Combinatorial Approach to Nanoarchitectonics for Nonviral Delivery of Nucleic Acids.Harnessing RNAi-based nanomedicines for therapeutic gene silencing in B-cell malignancies.Neutrophil-selective CD18 silencing using RNA interference in vivoInterfering with disease: a progress report on siRNA-based therapeutics.Durable knockdown and protection from HIV transmission in humanized mice treated with gel-formulated CD4 aptamer-siRNA chimerasNonviral delivery of synthetic siRNAs in vivo.Applying small RNA molecules to the directed treatment of human diseases: realizing the potential.Mammalian cell penetration, siRNA transfection, and DNA transfection by supercharged proteins.Mechanisms and strategies for effective delivery of antisense and siRNA oligonucleotides.Concepts in in vivo siRNA delivery for cancer therapy.Reversal of HIV-1 latency with anti-microRNA inhibitors.MicroRNAs as novel regulators of angiogenesis.Targeted delivery systems for oligonucleotide therapeutics.GapmeR cellular internalization by macropinocytosis induces sequence-specific gene silencing in human primary T-cells.
P2860
Q24603574-D32CBEEE-4B16-482A-A479-DDD0419E8689Q26770523-3B40DAD3-2906-4B0B-A403-FC651BA49598Q27490919-F7023D39-1174-4C80-BC8A-B48DD935558AQ27692125-2C8C77E6-F81B-4041-B251-CA74D172D193Q28082939-F54EB137-86AA-48CB-A6BD-18CAC8F20396Q28266775-56229D17-9F84-496A-B906-B744BFEF97BEQ33330928-94D8E9C7-D937-4013-B5DE-CB88A2DAC1E4Q33544140-C12EF287-D2E9-41A7-95A1-D4E5241791A7Q33613316-29FEEE68-2D38-4B3A-AA82-CF2AE0C1B59DQ33701022-079B3657-3FF0-474C-8FB6-ABC66395FFFEQ33717239-FE8FEC5C-8594-4690-9282-5EA96F44DC3BQ33730699-5A98B554-0AA2-4568-93D4-D46110B61B4DQ33751225-E8AC05DF-05EF-422F-A11C-49C1CB1968F2Q33776557-55CAD434-2F7B-445E-986B-3CA36801E0C3Q34013891-7F45FD65-28BC-4FB0-B0AE-2C1E41BA0630Q34092095-BDFEABEE-2A32-443B-8D84-1D3388B0386BQ34168738-549666FE-F1A6-4B1D-913C-0AC817FC99C5Q34659612-268ECF92-728C-4178-8FC5-7AD5AB27D997Q35015737-0AFE19DD-C77D-4572-AF82-188D6A1368CEQ35027512-2878360B-189D-4C7E-9E38-B68766490575Q35057551-C5FA2A60-D36E-4A64-8527-CFFEE9D6D47EQ35144394-02E0704E-7AE0-4C56-9D90-593132955E7FQ35551021-91838385-72F8-4BAA-96E9-325858EC135FQ35673875-15CC2477-3E45-441E-AEB9-F4E9E9A3C1A5Q35766249-9064C2D4-8CB8-49C6-A440-B97549BAA3ADQ35779648-49BC9D12-8B4A-4749-91DF-14FFBF7E1871Q35853451-52A48D79-7941-4C49-84FD-0ECA7E9CA5C3Q36459323-82FFA023-4833-4EEA-9130-66E2998C649AQ36508905-29462458-0857-401D-B031-7100D30781ACQ36836598-DC47D2AD-90D9-4CE4-BC3D-0C79BB0688CCQ36984469-AF6D93EA-10A9-4339-90D6-00786CB674ABQ37024768-DC3086E0-03CD-4CA9-A9D9-4EFE2A22630AQ37030891-0C48D182-258A-4BB2-A073-5595ECC04C7AQ37137996-877AF855-0C5D-4D21-AB49-FC8C6D63B96BQ37193000-77229CF5-4336-4555-A80B-42D4472C7897Q37217876-FD0EFF76-8DE8-411D-A5A7-8204636C2204Q37257647-DAF0771F-C317-4913-9D5D-4F4EA387E0F0Q37383695-34DEF48D-B602-43CA-92AC-37A859AC8C80Q37417572-D96D8021-6B2B-4CD4-A730-0B1BBEF1E5C6Q37435171-5176B07D-99EF-40DD-8641-A0A044C305F7
P2860
Selective gene silencing in activated leukocytes by targeting siRNAs to the integrin lymphocyte function-associated antigen-1.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Selective gene silencing in ac ...... function-associated antigen-1.
@ast
Selective gene silencing in ac ...... function-associated antigen-1.
@en
type
label
Selective gene silencing in ac ...... function-associated antigen-1.
@ast
Selective gene silencing in ac ...... function-associated antigen-1.
@en
prefLabel
Selective gene silencing in ac ...... function-associated antigen-1.
@ast
Selective gene silencing in ac ...... function-associated antigen-1.
@en
P2093
P2860
P356
P1476
Selective gene silencing in ac ...... function-associated antigen-1
@en
P2093
Judy Lieberman
Motomu Shimaoka
Pengcheng Zhu
P2860
P304
P356
10.1073/PNAS.0608491104
P407
P577
2007-02-28T00:00:00Z